Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Key trial updates from SABCS 2020

Komal Jhaveri • 11 Dec 2020
SABCS 2020
Breast Cancer
RxPONDER

Komal Jhaveri, MD, FACP, Memorial Sloan Kettering Cancer Center, New York, NY, explores practice changing data presented at this years annual San Antonio Breast Cancer Symposium (SABCS), these include the results of the RxPONDER trial which evaluated whether chemotherapy could be spared in women with node-positive early stage breast cancer based on OncoType Dx ® score. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Komal Jhaveri

Navigating treatment decisions for patients with HR+/ HER- mBC
1:48
Navigating treatment decisions for patients with HR+/ HER- mBC
Komal Jhaveri • 11 May 2023
Exploring novel therapeutic approaches in HR+/ HER2- mBC
2:06
Exploring novel therapeutic approaches in HR+/ HER2- mBC
Komal Jhaveri • 11 May 2023
Investigating targeted therapy combinations in metastatic HR+ breast cancer
3:15
Investigating targeted therapy combinations in metastatic HR+ breast cancer
Komal Jhaveri • 11 May 2023
Breast cancer trends in 2021 and beyond
1:18
Breast cancer trends in 2021 and beyond
Komal Jhaveri • 11 Dec 2020

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals